Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Total Liabilities (2023 - 2025)

Historic Total Liabilities for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $804275.0.

  • Mangoceuticals' Total Liabilities fell 4269.7% to $804275.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $804275.0, marking a year-over-year decrease of 4269.7%. This contributed to the annual value of $1.4 million for FY2024, which is 41639.91% up from last year.
  • Mangoceuticals' Total Liabilities amounted to $804275.0 in Q3 2025, which was down 4269.7% from $1.6 million recorded in Q2 2025.
  • Mangoceuticals' 5-year Total Liabilities high stood at $1.6 million for Q2 2025, and its period low was $240684.0 during Q3 2023.
  • Over the past 3 years, Mangoceuticals' median Total Liabilities value was $1.3 million (recorded in 2024), while the average stood at $1.0 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 48315.01% in 2024, then plummeted by 4269.7% in 2025.
  • Over the past 3 years, Mangoceuticals' Total Liabilities (Quarter) stood at $276039.0 in 2023, then soared by 416.4% to $1.4 million in 2024, then crashed by 43.58% to $804275.0 in 2025.
  • Its last three reported values are $804275.0 in Q3 2025, $1.6 million for Q2 2025, and $1.5 million during Q1 2025.